U.S. Software Stock News

CBIZ (NYSE:CBZ) reported weak underlying organic growth, while headline revenue gains were largely driven by acquisitions. Management flagged that some mid market client projects were postponed and issued a modest growth outlook for 2026. The update points to softer demand from key mid market clients and a greater reliance on acquired revenue. For investors watching NYSE:CBZ, the latest update comes after a sharp share price reset, with the stock down 24.1% over the past month and 41.2%...

NCR Voyix (NYSE: VYX) has secured 7-Eleven Philippines as a major new client. The agreement covers technology upgrades across more than 4,500 convenience stores. The engagement combines software platforms and professional services to support a broad retail technology refresh. NCR Voyix is adding this large 7-Eleven Philippines win at a time when the stock has faced pressure, with NYSE: VYX showing a 25.8% decline over the past year and a 63.7% decline over the past five years. At a recent...

Globe Life (NYSE:GL) announced an increase in its quarterly dividend, approved by the Board of Directors. Executive Vice President and Chief Strategy Officer Michael Clay Majors reported a significant sale of Globe Life shares. The combination of a higher dividend and sizable insider selling is drawing attention to management signals and capital allocation. Globe Life, trading at $144.69 at the last close, has seen its share price rise 1.7% over the past week, 3.2% over the past month, and...

Curtiss-Wright (NYSE:CW) entered a partnership with Averna to develop custom aerospace test systems, integrating advanced testing technology into its production process. The company secured a multi-year U.S. Department of Defense contract to supply shipboard helicopter handling systems, including RAST technology, to the U.S. Naval Air Warfare Center. Curtiss-Wright operates at the intersection of aerospace and defense hardware, supplying mission-critical systems to original equipment...

Credo Technology Group Holding (CRDO) has just posted Q3 2026 results with revenue of US$407.0 million and basic EPS of US$0.86, set against a trailing twelve month net income of US$339.8 million that reflects very large year over year earnings growth and a move into profitability over the last five years. The company has seen revenue move from US$135.0 million and basic EPS of US$0.17 in Q3 2025 to US$407.0 million and US$0.86 in Q3 2026, alongside trailing twelve month EPS stepping up from...

If you are wondering whether SL Green Realty's current share price really reflects what the business is worth, looking closely at how it is valued can help you frame that question more clearly. The stock last closed at US$39.05, with a 6.5% gain over the past week, a 12.8% decline over the last 30 days, a 16.8% decline year to date, a 33.8% decline over 1 year, a 43.6% return over 3 years, and a 28.0% decline over 5 years, which gives you a mixed picture of recent and longer term...

Director Jennifer Lynn Davis has sold a substantial stake in Bob's Discount Furniture around the time of the company's IPO. The transaction involves insider shares in NYSE:BOBS, drawing attention to governance and ownership changes as the company enters public markets. Investors are watching how this sale fits into Bob's Discount Furniture's broader post-IPO plans and capital structure. Bob's Discount Furniture, now trading as NYSE:BOBS, operates in the value focused home furnishings...

Penumbra (NYSE:PEN) has entered into a definitive agreement to be acquired by Boston Scientific. The all cash transaction values Penumbra at approximately US$14.5b. The deal is subject to approval by Penumbra shareholders and other customary closing conditions. Penumbra focuses on medical devices for neurovascular and peripheral vascular conditions, areas that continue to attract attention as populations age and care standards evolve. Boston Scientific’s agreement to acquire NYSE:PEN adds...

Root (ROOT) is back in focus after reporting fourth quarter and full year 2025 results, with revenue and earnings per share figures giving investors fresh detail on the insurer’s recent operating performance. See our latest analysis for Root. Root’s recent earnings have arrived following a sharp pullback in its share price, with a 30 day share price return of 23.06% and a year to date share price return showing a 32.58% decline. The 1 year total shareholder return of a 63.88% decline...

DXP Enterprises is shifting its core focus from oil and gas distribution to a broader industrial platform. The company is targeting sectors such as Water, Wastewater, Fire, and Data Centers, supported by fresh liquidity. An acquisition driven expansion plan is central to this repositioning of NasdaqGS:DXPE. DXP Enterprises, trading on NasdaqGS:DXPE, is drawing attention as it reshapes its business around essential infrastructure and industrial markets. The stock closed at $140.47, with a...

Calumet (NasdaqGS:CLMT) reports significant debt reduction and major cost cuts as part of a wider operational reset. The company secures a large loan from the U.S. Department of Energy to support its Montana Renewables MaxSAF 150 expansion. Management highlights record Specialty Products production and ongoing portfolio changes as it advances its renewable fuels strategy. Calumet comes into this news cycle with its shares at $27.89 and a very large 5 year return, indicating the stock has...

Sprout Social (SPT) is drawing fresh attention after announcing AI-focused product updates and a deeper Reddit partnership, moves that could influence how marketing teams assess the company’s role in high trust online communities. See our latest analysis for Sprout Social. The recent AI product launch and Reddit partnership come after a sharp reset in Sprout Social’s share price, with a 30 day share price return of a 24.31% decline and a 1 year total shareholder return of a 74.31% decline...

Nuvation Bio FY 2025 Earnings Snapshot Nuvation Bio (NUVB) has wrapped up FY 2025 with fourth quarter revenue of about US$41.9 million and a basic EPS loss of US$0.11, as the market weighs solid top line figures against continued bottom line pressure. The company has seen revenue move from US$5.7 million in Q4 2024 to US$41.9 million in Q4 2025, while quarterly basic EPS has ranged from a loss of US$0.15 in Q4 2024 to a loss of US$0.11 in Q4 2025 and a trailing twelve month basic EPS loss of...

Bausch Health Companies, trading at $5.73, has seen pressure on its share price over multiple time frames, with a 20.5% decline year to date and an 83.1% decline over five years. In that context, the continued work on a full split from Bausch + Lomb are central to how investors may reassess the company’s revenue mix and overall structure.

Best Buy FY 2026 results: revenue steady, EPS under pressure as margins stay thin Best Buy (BBY) has reported third quarter FY 2026 results with revenue of US$9.7b and basic EPS of US$0.66, setting the tone for a year where earnings quality is very much in focus. Over the past three quarters of FY 2026, revenue has ranged from US$8.8b to US$9.7b while basic EPS moved from US$0.95 in Q1 to US$0.88 in Q2 and US$0.66 in Q3, alongside same store sales trends that went from a 0.7% decline in Q1 to...

If you are wondering whether St. Joe's current share price still offers value, it helps to step back and look at what the numbers are really saying about the business. The stock last closed at US$72.79, with returns of 4.0% over 7 days, 10.0% over 30 days, 21.7% year to date, 56.8% over 1 year, 82.4% over 3 years and 56.4% over 5 years, which will naturally raise questions about how the current price lines up with underlying value. Investors have been watching St. Joe as it continues to...

If you are wondering whether ADT is attractively priced today or if the security specialist is a potential value trap in your portfolio, this article is for you. ADT shares last closed at US$6.85, with returns of a 13.1% decline over 7 days, a 14.4% decline over 30 days, a 14.5% decline year to date and a 7.3% decline over 1 year, while the 5 year return sits at 0.9%. These moves have kept ADT on many investors' watchlists, especially among those focused on how sentiment about home and...

Yatsen Holding (NYSE:YSG) has capped FY 2025 with fourth quarter revenue of C¥1.4b and basic EPS of C¥0.09, a clear contrast to the loss profile seen earlier in the year. The company has seen quarterly revenue move from C¥833.5m in Q1 2025 to C¥1.4b in Q4, while basic EPS has shifted from a loss of C¥0.06 in Q1 and C¥0.19 in Q2 to a profit in Q4, against a trailing twelve month EPS of a C¥1.35 loss and net income loss of C¥80.9m on C¥4.3b of revenue. That mix of stronger recent EPS and still...

ATI (NYSE:ATI) has appointed CEO Kimberly Fields as chair of the board, consolidating leadership roles at the company. Under Fields' leadership, ATI is moving to double forging output to support Pratt & Whitney and help address aerospace production constraints. ATI, traded as NYSE:ATI, supplies high performance materials and components to aerospace and other industrial customers. With aircraft manufacturers and engine makers working through production challenges, the reliability of key...

Assessing Alexander & Baldwin after recent performance shifts Alexander & Baldwin (ALEX) has drawn fresh attention as investors reassess its Hawai‘i focused commercial real estate portfolio in light of recent share performance and current earnings and revenue trends. See our latest analysis for Alexander & Baldwin. At a share price of US$20.83, Alexander & Baldwin has seen a 90 day share price return of 35.17%, while its 1 year total shareholder return of 24.02% suggests that momentum has...

Prime Medicine (PRME) has released fresh FY 2025 figures, with Q3 results showing total revenue of US$1.2 million and a basic EPS loss of US$0.32, as net income excluding extra items recorded a loss of US$50.6 million. The company’s quarterly revenue has moved from US$0.2 million in Q3 2024 to US$2.2 million in Q4 2024, then to US$1.5 million in Q1 2025, US$1.1 million in Q2 2025, and US$1.2 million in Q3 2025. Over the same period, basic EPS ranged between losses of US$0.32 and US$0.46 per...

Empire State Realty Trust (ESRT) closed out FY 2025 with Q4 revenue of US$199.2 million and basic EPS of US$0.12, alongside funds from operations of US$59.0 million and FFO per share of US$0.22. The company reported revenue of US$197.6 million in Q4 2024 and US$199.2 million in Q4 2025, while basic EPS moved from US$0.07 to US$0.12 over the same period. Trailing 12 month net margin was 5.7% compared with 6.2% a year ago, and a sizeable one off gain of US$34.9 million affected recent earnings...

Cerus (CERS) has just closed out FY 2025 with Q4 revenue of US$57.8 million and a basic EPS loss of US$0.01, while trailing 12 month figures sit at US$206.1 million in revenue and a basic EPS loss of US$0.08. Over recent quarters the company has seen revenue move from US$50.8 million in Q4 2024 to US$43.2 million in Q1 2025, then to US$52.4 million in Q2, US$52.7 million in Q3 and US$57.8 million in Q4, with basic EPS losses ranging between US$0.00 and US$0.04 per share across the same...

NB Bancorp's FY 2025 Earnings Snapshot NB Bancorp (NBBK) has just closed out FY 2025 with fourth quarter total revenue of US$64.2 million and basic EPS of US$0.19, alongside quarterly net income of US$7.7 million. Over the past year, the bank has seen total revenue move from US$44.9 million in Q4 FY 2024 to US$64.2 million in Q4 FY 2025, while quarterly EPS shifted from US$0.40 to US$0.19. With trailing 12 month earnings growth reported at 350.6% and net profit margin running at 30.7% versus...